Publication | Open Access
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8<sup>+</sup> T cell and XCR1<sup>+</sup> dendritic cell spatial co-localization
45
Citations
37
References
2022
Year
TIM-3 blockade increases exposure of intratumoral CD8<sup>+</sup> T cells to cDC1-derived cytokines, with implications for the design of therapeutic strategies using antibodies against TIM-3.
| Year | Citations | |
|---|---|---|
Page 1
Page 1